INHBA and esophageal adenocarcinoma: INHBA overexpression has been correlated with aggressive phenotype in different cancers, including colorectal cancer, lung adenocarcinoma, esophageal adenocarcinoma, ovarian cancer, and gastric cancer [11–15].